Literature DB >> 6451421

Immune complexes (ICs) and pregnancy. Pregnancy as an IC-state or IC-disease and the influence of IC-diseases on pregnancy.

N Gleicher, A N Theofilopoulos.   

Abstract

The immunologic tolerance of the fetoplacental allograft by the maternal immune system is still poorly understood. Recently published studies resulted in a widely publicized controversy on the presence or absence of immune complexes (ICs) in normal and abnormal pregnancies. The present review is an attempt to analyze presently known data critically and to reach subsequently derived conclusions which may be relevant to the understanding of the immunologic phenomenon of pregnancy. Pregnancy may represent an immune complex-state if the presence of ICs represents a physiologic state, or an immune complex-disease if ICs occur under special circumstances only, such as in the EPH-gestosis syndrome. In both of these instances, the presence of ICs may directly influence the maternal immune system, the fetal immune system, or result in very specific effects on associated immune complex-diseases. These effects and the possible influence of immune complex-diseases on normal pregnancy are extensively discussed. It is concluded that a clear definition of pregnancy as a possible IC-state or IC-disease is required. The confirmation of such a concept will necessitate a review of our clinical management protocols for a number of medical conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6451421

Source DB:  PubMed          Journal:  Diagn Gynecol Obstet        ISSN: 0196-9617


  2 in total

1.  Adverse effect of pregnancy on familial fibrosing alveolitis.

Authors:  M G Prichard; A W Musk
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

2.  Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.

Authors:  Fauzia Jamal; Pushkar Shivam; Sarita Kumari; Manish Kumar Singh; Abul Hasan Sardar; Selvasankar Murugesan; Shyam Narayan; Anil Kumar Gupta; Krishna Pandey; V N R Das; Vahab Ali; Sanjiva Bimal; Pradeep Das; Shubhankar K Singh
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.